Upcoming presentation

Invitation to presentation of Q3 2017 results

Biotec Pharmacon presents its report for the third quarter 2017. The presentation will be given by CEO Christian Jørgensen and MD ArcticZymes Jethro Holter.

The presentation starts at 08:30 a.m. and will be in English. It will be possible to post questions through the webcast console.

The interim report for the third quarter 2017 will be available on www.newsweb.no and on the company's homepage, www.biotec.no from 07:00 a.m. on 19. October 2017.

For further information, please contact:
CFO
Børge Sørvoll
+47 952 90187
borge.sorvoll@biotec.no

View the webcast

  • Recent news

  • ArcticZymes new product launch to serve the bio-manufacturing market segment

    Biotec Pharmacon ASA's subsidiary ArcticZymes has today launched its SAN HQ ELISA immunoassay product which is targeted towards the bio-manufacturing market. ArcticZymes business has largely focused on serving the molecular biology and diagnostics markets. Serving the bio-manufacturing market is a new direction for ArcticZymes in its efforts to expand into other relevant…

    Continue reading

Latest presentation

Presentation of the second quarter 2017

Loading video...

Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 16.4 million (15.3) in the second quarter of 2017, and a negative EBITDA of NOK 4.4 million (-1.6). Woulgan® generated sales of NOK 0.9, up from NOK 0.4 million in the first quarter of 2017 . ArcticZymes continued its positive sales growth…

View more